CRP and Stroke: These properties have been documented in several clinical contexts: during acute infections in otherwise healthy individuals [61]; in sarcopenic elderly patients with diabetes undergoing hypoglycemic therapy, where EAA supplementation reduced plasma TNF-α levels [62]; and in dysphagic stroke patients undergoing rehabilitation, where EAAs decreased CRP levels and improved swallowing function [63].